Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva de Lago

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|May 17, 2003
Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitorsMaría L López-Rodríguez, Alma Viso, Silvia Ortega-Gutiérrez, et al.
European Journal of Pharmacology|January 28, 2004
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptakeEva de Lago, Alessia Ligresti, Giorgio Ortar, et al.
Journal of Medicinal Chemistry|April 4, 2003
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolaseMaría L López-Rodríguez, Alma Viso, Silvia Ortega-Gutiérrez, et al.
British Journal of Pharmacology|January 24, 2021
Targeting the CB<sub>2</sub> receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosisCarmen Rodríguez-Cueto, Laura García-Toscano, Irene Santos-García, et al.
Forensic Science International|August 14, 2002
STR data for nine Y-chromosomal loci in Guinea Equatorial (central Africa)Sara Alvarez, María Soledad Mesa, Ana María López, et al.
The European Journal of Neuroscience|April 14, 2010
Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic painDevi Rani Sagar, Maulik D Jhaveri, Denise Richardson, et al.
Journal of Neuroinflammation|May 6, 2023
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male miceIrene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 12, 2026
Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP-43 Mouse Model of Frontotemporal DementiaHayatte-Dounia Mir, Giada Giorgini, Irene Santos-García, et al.
International Journal of Molecular Sciences|November 27, 2021
BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral SclerosisMarta Gómez-Almería, Sonia Burgaz, Carlos Costas-Insua, et al.
Neurobiology of Disease|October 26, 2005
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosisAna Cabranes, Katerina Venderova, Eva de Lago, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|May 17, 2003
Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitorsMaría L López-Rodríguez, Alma Viso, Silvia Ortega-Gutiérrez, et al.
European Journal of Pharmacology|January 28, 2004
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptakeEva de Lago, Alessia Ligresti, Giorgio Ortar, et al.
Journal of Medicinal Chemistry|April 4, 2003
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolaseMaría L López-Rodríguez, Alma Viso, Silvia Ortega-Gutiérrez, et al.
British Journal of Pharmacology|January 24, 2021
Targeting the CB<sub>2</sub> receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosisCarmen Rodríguez-Cueto, Laura García-Toscano, Irene Santos-García, et al.
Forensic Science International|August 14, 2002
STR data for nine Y-chromosomal loci in Guinea Equatorial (central Africa)Sara Alvarez, María Soledad Mesa, Ana María López, et al.
The European Journal of Neuroscience|April 14, 2010
Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic painDevi Rani Sagar, Maulik D Jhaveri, Denise Richardson, et al.
Journal of Neuroinflammation|May 6, 2023
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male miceIrene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 12, 2026
Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP-43 Mouse Model of Frontotemporal DementiaHayatte-Dounia Mir, Giada Giorgini, Irene Santos-García, et al.
International Journal of Molecular Sciences|November 27, 2021
BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral SclerosisMarta Gómez-Almería, Sonia Burgaz, Carlos Costas-Insua, et al.
Neurobiology of Disease|October 26, 2005
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosisAna Cabranes, Katerina Venderova, Eva de Lago, et al.
Pageof 5